Gordian Bio
San Francisco, United States · Founded 2018 · $1.5M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- gordian.bio
- Total Funding
- $1.5M
- Last Round
- $1.5M SeedApr 2020
- Rounds
- 2
About
Develops therapies for age-related diseases using high-throughput in vivo screening and AAV-based perturbations to identify and validate drug targets.
Summary
Gordian Bio is a Biotech company based in San Francisco, United States, founded in 2018. It has raised $1.5M in total across 2 rounds, most recently a $1.5M Seed round in Apr 2020. Investors include The Longevity Fund, Prime Movers Lab and Fifty Years.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.